GB0612428D0 - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
GB0612428D0
GB0612428D0 GBGB0612428.3A GB0612428A GB0612428D0 GB 0612428 D0 GB0612428 D0 GB 0612428D0 GB 0612428 A GB0612428 A GB 0612428A GB 0612428 D0 GB0612428 D0 GB 0612428D0
Authority
GB
United Kingdom
Prior art keywords
antibacterial agents
antibacterial
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0612428.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prolysis Ltd
Original Assignee
Prolysis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolysis Ltd filed Critical Prolysis Ltd
Priority to GBGB0612428.3A priority Critical patent/GB0612428D0/en
Publication of GB0612428D0 publication Critical patent/GB0612428D0/en
Priority to MYPI20085070 priority patent/MY148682A/en
Priority to NZ574313A priority patent/NZ574313A/en
Priority to PL07733310T priority patent/PL2034997T3/pl
Priority to EA200900047A priority patent/EA019748B1/ru
Priority to MX2008015706A priority patent/MX2008015706A/es
Priority to KR1020097001499A priority patent/KR101443795B1/ko
Priority to EP20070733310 priority patent/EP2034997B1/en
Priority to DK07733310T priority patent/DK2034997T3/da
Priority to CN200780023251XA priority patent/CN101472585B/zh
Priority to AU2007262791A priority patent/AU2007262791B2/en
Priority to SG2011040847A priority patent/SG172676A1/en
Priority to CA2655403A priority patent/CA2655403C/en
Priority to BRPI0713501-7A priority patent/BRPI0713501A2/pt
Priority to PT07733310T priority patent/PT2034997E/pt
Priority to ES07733310T priority patent/ES2403005T3/es
Priority to PCT/GB2007/002314 priority patent/WO2007148093A1/en
Priority to JP2009515958A priority patent/JP5309021B2/ja
Priority to US12/304,303 priority patent/US7977340B2/en
Priority to IL195687A priority patent/IL195687A/en
Priority to ZA2009/00240A priority patent/ZA200900240B/en
Priority to US13/154,592 priority patent/US8389516B2/en
Priority to US13/154,485 priority patent/US8481544B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB0612428.3A 2006-06-22 2006-06-22 Antibacterial agents Ceased GB0612428D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB0612428.3A GB0612428D0 (en) 2006-06-22 2006-06-22 Antibacterial agents
US12/304,303 US7977340B2 (en) 2006-06-22 2007-06-21 Antibacterial compositions
AU2007262791A AU2007262791B2 (en) 2006-06-22 2007-06-21 Antibacterial compositions
CA2655403A CA2655403C (en) 2006-06-22 2007-06-21 Antibacterial benzothiazoles and thiazolopyridines
PL07733310T PL2034997T3 (pl) 2006-06-22 2007-06-21 Kompozycje przeciwbakteryjne
EA200900047A EA019748B1 (ru) 2006-06-22 2007-06-21 Антибактериальные композиции
MX2008015706A MX2008015706A (es) 2006-06-22 2007-06-21 Composiciones antibacterianas.
KR1020097001499A KR101443795B1 (ko) 2006-06-22 2007-06-21 항균성 조성물
EP20070733310 EP2034997B1 (en) 2006-06-22 2007-06-21 Antibacterial compositions
DK07733310T DK2034997T3 (da) 2006-06-22 2007-06-21 Antibakterielle sammensætninger
CN200780023251XA CN101472585B (zh) 2006-06-22 2007-06-21 抗菌组合物
MYPI20085070 MY148682A (en) 2006-06-22 2007-06-21 Antibacterial compositions
SG2011040847A SG172676A1 (en) 2006-06-22 2007-06-21 Antibacterial compositions
NZ574313A NZ574313A (en) 2006-06-22 2007-06-21 Antibacterial compositions
BRPI0713501-7A BRPI0713501A2 (pt) 2006-06-22 2007-06-21 composições antibacterianas
PT07733310T PT2034997E (pt) 2006-06-22 2007-06-21 Composições antibacterianas
ES07733310T ES2403005T3 (es) 2006-06-22 2007-06-21 Composiciones antibacterianas
PCT/GB2007/002314 WO2007148093A1 (en) 2006-06-22 2007-06-21 Antibacterial compositions
JP2009515958A JP5309021B2 (ja) 2006-06-22 2007-06-21 抗菌組成物
IL195687A IL195687A (en) 2006-06-22 2008-12-03 Benzo-thiazole and thiazolo-pyridine for use in the treatment of bacterial infections
ZA2009/00240A ZA200900240B (en) 2006-06-22 2009-01-12 Antibacterial compositions
US13/154,592 US8389516B2 (en) 2006-06-22 2011-06-07 Antibacterial compositions
US13/154,485 US8481544B2 (en) 2006-06-22 2011-06-07 Antibacterial compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0612428.3A GB0612428D0 (en) 2006-06-22 2006-06-22 Antibacterial agents

Publications (1)

Publication Number Publication Date
GB0612428D0 true GB0612428D0 (en) 2006-08-02

Family

ID=36803739

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0612428.3A Ceased GB0612428D0 (en) 2006-06-22 2006-06-22 Antibacterial agents

Country Status (21)

Country Link
US (2) US7977340B2 (enExample)
EP (1) EP2034997B1 (enExample)
JP (1) JP5309021B2 (enExample)
KR (1) KR101443795B1 (enExample)
CN (1) CN101472585B (enExample)
AU (1) AU2007262791B2 (enExample)
BR (1) BRPI0713501A2 (enExample)
CA (1) CA2655403C (enExample)
DK (1) DK2034997T3 (enExample)
EA (1) EA019748B1 (enExample)
ES (1) ES2403005T3 (enExample)
GB (1) GB0612428D0 (enExample)
IL (1) IL195687A (enExample)
MX (1) MX2008015706A (enExample)
MY (1) MY148682A (enExample)
NZ (1) NZ574313A (enExample)
PL (1) PL2034997T3 (enExample)
PT (1) PT2034997E (enExample)
SG (1) SG172676A1 (enExample)
WO (1) WO2007148093A1 (enExample)
ZA (1) ZA200900240B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0612428D0 (en) 2006-06-22 2006-08-02 Prolysis Ltd Antibacterial agents
GB0724349D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Antibacterial agents
US8481544B2 (en) 2006-06-22 2013-07-09 Biota Europe Limited Antibacterial compositions
DE602007014256D1 (de) 2006-12-04 2011-06-09 Astrazeneca Ab Antibakterielle polycyclische harnstoffverbindungen
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
WO2009156966A1 (en) * 2008-06-25 2009-12-30 Ranbaxy Laboratories Limited Benzothiazoles and aza-analogues thereof use as antibacterial agents
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
EP2277870A1 (de) * 2009-06-24 2011-01-26 Bayer CropScience AG Substituierte Benzoxa(thia)zole
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
MX2012010666A (es) 2010-03-31 2012-10-05 Actelion Pharmaceuticals Ltd Derivados de isoquinolin-3-ilurea antibacterianos.
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151621A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
US8481551B2 (en) 2011-01-14 2013-07-09 Vertex Pharmaceuticals Incorporated Gyrase and topoisomerase IV inhibitors
CN103384666A (zh) 2011-01-14 2013-11-06 沃泰克斯药物股份有限公司 固体形式的促旋酶抑制剂（r）-1-乙基-3-[5-[2-（1-羟基-1-甲基-乙基）嘧啶-5-基]-7-（四氢呋喃-2-基）-1氢-苯并咪唑-2-基]脲
CN103403000B (zh) 2011-01-14 2017-05-31 斯派罗吹耐姆公司 固体形式的促旋酶抑制剂（r）‑1‑乙基‑3‑[6‑氟‑5‑[2‑（1‑羟基‑1‑甲基‑乙基）嘧啶‑5‑基]‑7‑（四氢呋喃‑2‑基）‑1氢‑苯并咪唑‑2‑基]脲
NZ612920A (en) 2011-01-14 2015-10-30 Vertex Pharma Process of making gyrase and topoisomerase iv inhibitors
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
KR101941420B1 (ko) 2011-06-20 2019-01-23 스페로 트리넴, 인코포레이티드 자이라제 및 토포이소머라제 억제제의 인산에스테르
US9822108B2 (en) 2012-01-13 2017-11-21 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013142712A1 (en) 2012-03-21 2013-09-26 Rutgers, The State University Of New Jersey Antimicrobial agents
HK1206031A1 (en) * 2012-03-22 2015-12-31 生物区欧洲有限公司 Antibacterial compounds
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
TWI595002B (zh) 2012-07-18 2017-08-11 思沛羅三南公司 （Ｒ）－２－（５－（２－（３－乙基脲基）－６－氟－７－（四氫呋喃－２－基）－１Ｈ－苯并［ｄ］咪唑－５－基）嘧啶－２－基）丙烷－２－基磷酸二氫鹽之固體形式及其鹽
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US20160194279A1 (en) * 2012-12-09 2016-07-07 Council Of Scientific & Industrial Research One pot process for the conversion of aroyl chlorides to acyl thioureas
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
CA2938459A1 (en) 2014-02-03 2015-08-06 Spero Gyrase, Inc. Antibacterial compounds
KR102373700B1 (ko) 2014-04-02 2022-03-11 인터뮨, 인크. 항섬유성 피리디논
WO2016087417A1 (de) * 2014-12-02 2016-06-09 Bayer Cropscience Aktiengesellschaft Bicyclische verbindungen als schädlingsbekämpfungsmittel
US20180000793A1 (en) * 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
AR104259A1 (es) 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
CN106167486B (zh) * 2015-05-22 2019-06-14 北京四环制药有限公司 单环类回旋酶和拓扑异构酶iv抑制剂
EP3419967A4 (en) 2016-02-25 2019-10-16 Taxis Pharmaceuticals, Inc. METHODS AND INTERMEDIARIES FOR SYNTHESIS
EP3568395A1 (de) 2017-01-10 2019-11-20 Bayer Aktiengesellschaft Heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3604281A4 (en) 2017-03-24 2020-08-19 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
CA3058183A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
TWI820231B (zh) 2018-10-11 2023-11-01 德商拜耳廠股份有限公司 用於製備經取代咪唑衍生物之方法
JP7730803B2 (ja) 2019-07-17 2025-08-28 サミット （オックスフォード） リミティド リジニラゾールの調製方法およびその結晶形態
CN116033828B (zh) 2020-07-02 2025-05-16 拜耳公司 作为害虫防治剂的杂环衍生物
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
EP4398890A4 (en) 2021-09-09 2025-07-30 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The Univ Of Nevada Las Ve C. Difficile Spore Germination Inhibitors
CN116444376B (zh) * 2023-04-19 2024-01-26 德兴市德邦化工有限公司 一种3,5-二氯硝基苯的生产工艺
WO2025026738A1 (en) 2023-07-31 2025-02-06 Bayer Aktiengesellschaft 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides
CN119350937B (zh) * 2024-10-30 2025-08-12 广东豪之盛新材料有限公司 一种双组份气雾喷漆及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810988A (en) * 1968-11-01 1974-05-14 Ciba Geigy Ag Control of phytopathogenic fungi with n-benzothiazae-2-yl n-{40 {11 propylure
CH505543A (de) * 1968-11-01 1971-04-15 Ciba Geigy Ag Schädlingsbekämpfungsmittel
US4028374A (en) * 1975-11-03 1977-06-07 Morton-Norwich Products, Inc. Antibacterial thiocyanatobenzothiazoles
AU2001236698A1 (en) * 2000-02-07 2001-08-14 Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
CN1234358C (zh) * 2000-06-21 2006-01-04 弗·哈夫曼-拉罗切有限公司 苯并噻唑衍生物
DE60139964D1 (de) * 2000-12-15 2009-10-29 Vertex Pharma Bakterielle Gyrase-Hemmer sowie deren Verwendung
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
EP1680431A1 (en) 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
CN101676270A (zh) * 2004-09-09 2010-03-24 中外制药株式会社 新型四氢咪唑衍生物及其用途
GB0612428D0 (en) 2006-06-22 2006-08-02 Prolysis Ltd Antibacterial agents

Also Published As

Publication number Publication date
SG172676A1 (en) 2011-07-28
EA019748B1 (ru) 2014-06-30
KR101443795B1 (ko) 2014-10-21
CA2655403C (en) 2014-02-04
EP2034997A1 (en) 2009-03-18
WO2007148093A1 (en) 2007-12-27
PT2034997E (pt) 2013-01-24
AU2007262791B2 (en) 2012-11-08
US8389516B2 (en) 2013-03-05
NZ574313A (en) 2011-10-28
JP2009541289A (ja) 2009-11-26
DK2034997T3 (da) 2013-02-11
IL195687A0 (en) 2009-09-01
US7977340B2 (en) 2011-07-12
JP5309021B2 (ja) 2013-10-09
CN101472585A (zh) 2009-07-01
BRPI0713501A2 (pt) 2012-03-13
PL2034997T3 (pl) 2013-04-30
EA200900047A1 (ru) 2009-06-30
ZA200900240B (en) 2009-12-30
EP2034997B1 (en) 2012-10-17
CA2655403A1 (en) 2007-12-27
KR20090029817A (ko) 2009-03-23
MY148682A (en) 2013-05-31
US20110263590A1 (en) 2011-10-27
US20090197877A1 (en) 2009-08-06
CN101472585B (zh) 2013-12-04
MX2008015706A (es) 2009-03-31
AU2007262791A1 (en) 2007-12-27
IL195687A (en) 2013-12-31
ES2403005T3 (es) 2013-05-13

Similar Documents

Publication Publication Date Title
GB0612428D0 (en) Antibacterial agents
GB0724349D0 (en) Antibacterial agents
GB0724278D0 (en) uses for antimicrobial agents
IL196865A0 (en) Antimicrobials
EP2007377A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
GB0815484D0 (en) Antibacterial agents
IL202487A0 (en) Contrast agents
GB0718735D0 (en) Antibacterial agents
IL185899A0 (en) Antibacterial amide-macrocycles v
ZA200903041B (en) Combination
GB0601687D0 (en) Antimicrobial materials
EP1988901A4 (en) Ceacam based antibacterial agents
EP1846411A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
ZA200808035B (en) Antibacterial agents
EP1846417A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
EP1846418A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
EP1845995A4 (en) ANTIBACTERIAL AGENTS
EP1846416A4 (en) ANTIBACTERIAL AGENTS
GB0609530D0 (en) Combination
ZA200809821B (en) Novel antibacterial compounds
GB0609619D0 (en) Combination
EP1962864A4 (en) ANTIBACTERIAL AGENTS
GB0718023D0 (en) Anti-bacterial agents
GB0623070D0 (en) Antibacterial agents
GB0718738D0 (en) Antibacterial agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)